Headache News and Research

Latest Headache News and Research

Health risks increase in Guyana with leptospirosis

Leptospirosis has become a health concern in Guyana, as the number of cases continues to rise and 43 people were being treated for suspected cases of the bacterial disease, which is usually caused by exposure to water contaminated with the urine of infected animals.

8 Feb 2005

Transient ischemic attack (TIA) patients receive less aggressive attention than those with stroke

Transient ischemic attack (TIA) patients receive less aggressive diagnostic testing, treatment and education compared to stroke patients, which is a missed opportunity to prevent permanent disability or death, researchers reported at the American Stroke Association's International Stroke Conference 2005.

3 Feb 2005

Scientists are a step closer to developing drug targets to treat fungal meningitis

Scientists are a step closer to developing drug targets to treat fungal meningitis -- the infection linked to at least three deaths on Vancouver Island -- thanks to the sequencing of two Cryptococcus genomes by an international team that included researchers at the University of British Columbia and the BC Cancer Agency's Michael Smith Genome Sciences Centre in Vancouver.

17 Jan 2005

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Sanofi pasteur, the vaccines business of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has licensed Menactra (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for protection against meningococcal disease in adolescents and adults aged 11-55 years.

17 Jan 2005

Investigation of possible link between migraine and a common heart defect, called a patent foramen ovale (PFO)

Doctors have received approval to investigate the possible link between migraine headache and a common heart defect, called a patent foramen ovale (PFO), which research indicates is prevalent in up to 25% of the general population or 15 million people in the UK.

16 Jan 2005

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.

7 Jan 2005

Economic impact of migraine headaches on American businesses is staggering

With more than 28 million Americans suffering from debilitating migraine headaches each year, employers also suffer through missed days from work and reduced productivity.

30 Dec 2004

People with migraine headaches report more angina, but not more heart disease

People with a history of migraines and other headaches lasting at least four hours are more likely to report suffering from the chest pain doctors call angina than people who do not experience such headaches, a new University of North Carolina at Chapel Hill study concludes.

28 Dec 2004

Oral medication alitretinoin effective in treating moderate or severe hand dermatitis

Use of the oral medication alitretinoin was effective in treating moderate or severe hand dermatitis in nearly half of patients previously unresponsive to standard treatment, according to an article in the December issue of The Archives of Dermatology.

20 Dec 2004

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Vaccinating large populations of white-footed mice against the bacterium that causes Lyme disease could help reduce the risk of transmission of the disease to humans, says a study supported by the National Institute of Allergy and Infectious Diseases (NIAID).

14 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Key molecular signal allows malarial parasites to target human red blood cells

Northwestern University researchers have identified a key molecular "signal" that allows malarial parasites to release virulence proteins inside human red blood cells.

13 Dec 2004

Migraine sufferers are twice as likely to suffer a stroke than those who don't experience migraines

In the first review of its kind, researchers in Canada and the US looked at 14 studies which investigated an association between stroke and migraine. They found that the risk of stroke for migraine sufferers was 2.16 times that for non-sufferers.

13 Dec 2004

Cognitive behaviour therapy helps adolescents with chronic fatigue syndrome

Psychological support, in the form of cognitive behaviour therapy, is an effective treatment for adolescents with chronic fatigue syndrome, finds a new study published on bmj.com today.

6 Dec 2004

Pennsylvania confirms first influenza case

Pennsylvania Health Secretary Dr. Calvin B. Johnson has announced that a 13-year-old Philadelphia County teen has the season's first, lab-confirmed case of flu.

4 Dec 2004

FDA approval of cream to treat bacterial vaginosis

KV Pharmaceutical Company has announced that it has received approval from the United States Food and Drug Administration (FDA) to market Clindesse (clindamycin phosphate) Vaginal Cream, 2%, a single-dose prescription cream therapy indicated to treat bacterial vaginosis ("BV").

3 Dec 2004

Novel anti-obesity compound shows promise for treatment of obesity

Arena Pharmaceuticals announced today results from the dosing phase of its Phase 1b clinical trial of APD356, an orally administered small molecule designed to regulate satiety (and perhaps metabolism) for the treatment of obesity.

30 Nov 2004

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

Forest Laboratories have announced that Combunox (Oxycodone HCl and Ibuprofen) Tablets (CII), the first and only fixed-dose combination of the opioid oxycodone HCl (5 mg) and the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen (400 mg), was approved by the U.S. Food and Drug Administration (FDA) for the short-term management of acute, moderate to severe pain.

29 Nov 2004

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

United Therapeutics Corporation announced today that the U.S. Food and Drug Administration (FDA) has issued an approval letter for the intravenous use of Remodulin based on data establishing its bioequivalence with the previously approved subcutaneous administration of Remodulin.

24 Nov 2004

FDA approval of Tysabri, for the treatment of multiple sclerosis

Biogen and Elan Corporation have announced that the U.S. Food and Drug Administration (FDA) has approved Tysabri (natalizumab), as treatment for relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical relapses.

24 Nov 2004

Headache News and Research

Latest Headache News and Research

Health risks increase in Guyana with leptospirosis

Transient ischemic attack (TIA) patients receive less aggressive attention than those with stroke

Scientists are a step closer to developing drug targets to treat fungal meningitis

FDA licenses Sanofi pasteur vaccine for protection against meningococcal disease

Investigation of possible link between migraine and a common heart defect, called a patent foramen ovale (PFO)

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Economic impact of migraine headaches on American businesses is staggering

People with migraine headaches report more angina, but not more heart disease

Oral medication alitretinoin effective in treating moderate or severe hand dermatitis

Vaccinating mice against Lyme disease could help reduce the risk of transmission of the disease to humans

Detrol LA significantly reduces symptoms of overactive bladder

Key molecular signal allows malarial parasites to target human red blood cells

Migraine sufferers are twice as likely to suffer a stroke than those who don't experience migraines

Cognitive behaviour therapy helps adolescents with chronic fatigue syndrome

Pennsylvania confirms first influenza case

FDA approval of cream to treat bacterial vaginosis

Novel anti-obesity compound shows promise for treatment of obesity

FDA approves Combunox tablets for the short-term treatment of acute, moderate to severe pain

FDA approves Remodulin for the treatment of pulmonary arterial hypertension

FDA approval of Tysabri, for the treatment of multiple sclerosis

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Headache News and Research

Latest Headache News and Research

Innovation in neuroscience drug discovery - eBook eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in